| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of MHC class I biosynthetic process | 4.18e-05 | 6 | 35 | 2 | GO:0045345 | |
| GeneOntologyBiologicalProcess | regulation of MHC class I biosynthetic process | 7.78e-05 | 8 | 35 | 2 | GO:0045343 | |
| GeneOntologyBiologicalProcess | MHC class I biosynthetic process | 7.78e-05 | 8 | 35 | 2 | GO:0045341 | |
| MousePheno | kidney papillary hypoplasia | 3.58e-05 | 5 | 27 | 2 | MP:0011565 | |
| Domain | Leu-rich_rpt | 1.13e-03 | 271 | 32 | 4 | IPR001611 | |
| Domain | - | 2.11e-03 | 321 | 32 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 2.28e-03 | 328 | 32 | 4 | IPR032675 | |
| Domain | LRR | 4.84e-03 | 201 | 32 | 3 | PS51450 | |
| Domain | - | 6.37e-03 | 222 | 32 | 3 | 1.25.10.10 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 25967872 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 27782176 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 1.02e-04 | 15 | 35 | 2 | 38871984 | |
| Pubmed | 1.17e-04 | 16 | 35 | 2 | 20301772 | ||
| Pubmed | 1.41e-04 | 100 | 35 | 3 | 10048485 | ||
| Pubmed | Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia. | 1.49e-04 | 18 | 35 | 2 | 31911949 | |
| Pubmed | 2.51e-04 | 1285 | 35 | 7 | 35914814 | ||
| Pubmed | 2.91e-04 | 25 | 35 | 2 | 36708875 | ||
| Pubmed | 2.99e-04 | 129 | 35 | 3 | 23022380 | ||
| Pubmed | 3.62e-04 | 963 | 35 | 6 | 28671696 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 4.54e-04 | 1005 | 35 | 6 | 19615732 | |
| Pubmed | 4.79e-04 | 32 | 35 | 2 | 33669244 | ||
| Pubmed | 4.93e-04 | 153 | 35 | 3 | 10718198 | ||
| Pubmed | [IMAGE: molecular integration of the analysis of the human genome and its expression]. | 5.73e-04 | 35 | 35 | 2 | 7757816 | |
| Pubmed | Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development. | 6.25e-04 | 166 | 35 | 3 | 19906978 | |
| Pubmed | 7.26e-04 | 407 | 35 | 4 | 15772651 | ||
| Pubmed | 7.26e-04 | 407 | 35 | 4 | 12693553 | ||
| Pubmed | 8.82e-04 | 187 | 35 | 3 | 26460568 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 1.02e-05 | 177 | 35 | 4 | chr15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.95e-04 | 147 | 35 | 3 | chr15q15 | |
| Cytoband | 15q21.2 | 2.26e-04 | 29 | 35 | 2 | 15q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 6.26e-03 | 155 | 35 | 2 | chr1p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 7.66e-03 | 172 | 35 | 2 | chrXq22 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.15e-06 | 170 | 34 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 2.85e-05 | 795 | 34 | 8 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.34e-05 | 115 | 34 | 4 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 2.16e-04 | 791 | 34 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 2.27e-04 | 1370 | 34 | 9 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 2.37e-04 | 803 | 34 | 7 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.06e-04 | 204 | 34 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_1000 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-08 | 200 | 35 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-07 | 180 | 35 | 5 | f24d4cbba4cb50fce3b3d9c4629aa856d9b05358 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.46e-07 | 197 | 35 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.46e-07 | 197 | 35 | 5 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.69e-07 | 199 | 35 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.69e-07 | 199 | 35 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.69e-07 | 199 | 35 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 200 | 35 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 200 | 35 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 200 | 35 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.18e-06 | 169 | 35 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 191 | 35 | 4 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 192 | 35 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.55e-05 | 193 | 35 | 4 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.55e-05 | 193 | 35 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 194 | 35 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 194 | 35 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 197 | 35 | 4 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.71e-05 | 198 | 35 | 4 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 35 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 35 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 199 | 35 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 35 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.78e-05 | 200 | 35 | 4 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Neuronal|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 20 | 35 | 2 | 383fa9245ad41596b085fe4c33dc8e910f43538a | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.19e-04 | 122 | 35 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 145 | 35 | 3 | 42dd36c1bc2c43cfea7196e89f901e4ea2a403c7 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.61e-04 | 159 | 35 | 3 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 163 | 35 | 3 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 165 | 35 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 165 | 35 | 3 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 165 | 35 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.07e-04 | 168 | 35 | 3 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-04 | 169 | 35 | 3 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.12e-04 | 169 | 35 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.17e-04 | 170 | 35 | 3 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.17e-04 | 170 | 35 | 3 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.17e-04 | 170 | 35 | 3 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 171 | 35 | 3 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 171 | 35 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 171 | 35 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-04 | 174 | 35 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 177 | 35 | 3 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 177 | 35 | 3 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.81e-04 | 181 | 35 | 3 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-04 | 181 | 35 | 3 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-04 | 184 | 35 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-04 | 186 | 35 | 3 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-04 | 187 | 35 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.19e-04 | 187 | 35 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-04 | 188 | 35 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-04 | 189 | 35 | 3 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-04 | 189 | 35 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.39e-04 | 190 | 35 | 3 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-04 | 190 | 35 | 3 | da60bcc4b59d8e3719d8201387d567594059b1a4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-04 | 190 | 35 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-04 | 190 | 35 | 3 | 827a1f4e4ac4beada262f4fb965dd74a447a8f4f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 190 | 35 | 3 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-04 | 191 | 35 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.46e-04 | 191 | 35 | 3 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.46e-04 | 191 | 35 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-04 | 191 | 35 | 3 | 054e9a79bd1486fd812bc7418fb091664fe3a646 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-04 | 191 | 35 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Neuronal|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.50e-04 | 40 | 35 | 2 | a55d9861170f41049748cd093d3d680855553d1d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Neuronal-Neurons|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.50e-04 | 40 | 35 | 2 | 7d7dc8dd5b095b7e3a83cbf840c4ee4f650bbc7c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 192 | 35 | 3 | 9479e9859140ba98abfe88414de0b28fc2bf43b7 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 192 | 35 | 3 | d7faa993f68e530ad55185505384ae155d36c222 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.53e-04 | 192 | 35 | 3 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | 4fc98f30f8e738816cd93101fbe8ac40889e302a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 192 | 35 | 3 | be75783d9578974b662e1cb13bd3442a921fd50a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-04 | 192 | 35 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-04 | 193 | 35 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-04 | 193 | 35 | 3 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-04 | 193 | 35 | 3 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.60e-04 | 193 | 35 | 3 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-04 | 193 | 35 | 3 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-04 | 194 | 35 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.67e-04 | 194 | 35 | 3 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.67e-04 | 194 | 35 | 3 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| Disease | MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE | 1.21e-06 | 2 | 33 | 2 | C1858516 | |
| Disease | Autosomal recessive primary microcephaly | 1.26e-04 | 15 | 33 | 2 | cv:C3711387 | |
| Disease | Primary microcephaly | 2.76e-04 | 22 | 33 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.76e-04 | 22 | 33 | 2 | C3711387 | |
| Disease | acne | 3.69e-04 | 125 | 33 | 3 | EFO_0003894 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLCNQMRQMVQDFDH | 651 | O94986 | |
| NTLMDHQHSNSMDNL | 331 | Q69YQ0 | |
| NLHAIHSMCRMEQDQ | 301 | A7MBM2 | |
| QCASLNGVNQDSHMM | 416 | Q9UHI8 | |
| QDAEMAMAECQNDSG | 366 | Q15139 | |
| QNLVQQACSSMAEMD | 411 | Q6UWE0 | |
| MNSCLHSQDEQKSMQ | 756 | Q9Y6X6 | |
| NEMSSEADMECLNQR | 506 | Q92598 | |
| LMTMCQDSNQNDERS | 46 | P41279 | |
| ENHKNDMDITQSCMV | 1106 | Q8NG31 | |
| DENIPSMEMCDQRHN | 361 | Q5XXA6 | |
| MNDSDTHENSLMDQN | 1456 | P23471 | |
| AAIMNANENNVDSMS | 1921 | Q8NFC6 | |
| IMDSANSNFMINCES | 2781 | Q8NCM8 | |
| SHVMQEESANDMECE | 31 | Q5JV73 | |
| DNVAEMHMALNNQAT | 266 | H7C350 | |
| VATQNHMDMCSESQV | 486 | Q49AJ0 | |
| ACNDMTPEQMATNVN | 31 | P21781 | |
| MDAHEAAQMHQNFSQ | 556 | Q9Y6X3 | |
| EMSRQCHALQEDMQT | 86 | Q494R4 | |
| QDNQLCMEEAMNSSH | 41 | Q8TBY8 | |
| DSNRSMHMANQEANT | 221 | Q5JY77 | |
| DSQCMAAMNFQTMHN | 376 | Q9UNP4 | |
| MADVMAACSDNLHNL | 4496 | Q9P2P6 | |
| QDAMCETMEQQLSSD | 511 | Q9NPQ8 | |
| EMMDQAAAQLAQDNC | 1486 | A5YKK6 | |
| LCNHEDQNMQRMAVA | 456 | Q9C0D3 | |
| QMMDHLDCATNEENP | 496 | Q8TCT8 | |
| QSMTLQCAQDMNHNS | 36 | A0A0K0K1D8 | |
| AQLHVMNNNMSEEDE | 286 | P51784 | |
| AHQMTMDDSENNFQN | 791 | Q96QT4 | |
| HVCLFTINNMNDCSM | 106 | Q8WZ26 | |
| TINNMNDCSMDAAER | 111 | Q8WZ26 | |
| DNMVECQLETHNNKM | 756 | Q9BYP7 | |
| NCREMNQSATECSMQ | 251 | P59046 | |
| NMTDEHGNMVNLVCD | 321 | Q9NR99 | |
| NDNEMLFHSCQMVEE | 351 | Q5VVJ2 | |
| HQMNCHNTRIMQDTE | 171 | Q9UL68 |